Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

被引：0
|
作者：
César Fernández-de-las-Peñas
Juan Torres-Macho
Jesus Alfonso Catahay
Raymart Macasaet
Jacqueline Veronica Velasco
Sharina Macapagal
Mario Caldararo
Brandon Michael Henry
Giuseppe Lippi
Ana Franco-Moreno
Kin Israel Notarte
机构：
[1] Universidad Rey Juan Carlos (URJC),Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud
[2] Universidad Rey Juan Carlos,Department of Internal Medicine
[3] Hospital Universitario Infanta Leonor-Virgen de La Torre,Department of Medicine, School of Medicine
[4] Universidad Complutense de Madrid,Department of Medicine
[5] Saint Peter’s University Hospital,Department of Medicine
[6] Monmouth Medical Center,Faculty of Medicine and Surgery
[7] University of Santo Tomas,Department of Medicine, John A. Burns School of Medicine
[8] University of Hawaii,Clinical Laboratory, Division of Nephrology and Hypertension
[9] Cincinnati Children’s Hospital Medical Center,Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement
[10] University of Verona,Department of Pathology
[11] Johns Hopkins University School of Medicine,undefined
来源：
Infection | 2024年 / 52卷
关键词：
Antiviral; Remdesivir; Nirmatrelvir/Ritonavir; Long-COVID; Post-COVID-19; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：43 / 58
页数：15
相关论文
共 50 条
  • [1] Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review
    Fernandez-de-las-Penas, Cesar
    Torres-Macho, Juan
    Catahay, Jesus Alfonso
    Macasaet, Raymart
    Velasco, Jacqueline Veronica
    Macapagal, Sharina
    Caldararo, Mario
    Henry, Brandon Michael
    Lippi, Giuseppe
    Franco-Moreno, Ana
    Notarte, Kin Israel
    [J]. INFECTION, 2024, 52 (01) : 43 - 58
  • [2] Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review (vol 52, pg 43, 2023)
    Fernandez-de-las-Penas, Cesar
    Torres-Macho, Juan
    Catahay, Jesus Alfonso
    Macasaet, Raymart
    Velasco, Jacqueline Veronica
    Macapagal, Sharina
    Caldararo, Mario
    Henry, Brandon Michael
    Lippi, Giuseppe
    Franco-Moreno, Ana
    Notarte, Kin Israel
    [J]. INFECTION, 2024,
  • [3] Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
    Notarte, Kin Israel
    Catahay, Jesus Alfonso
    Velasco, Jacqueline Veronica
    Pastrana, Adriel
    Ver, Abbygail Therese
    Pangilinan, Flos Carmeli
    Peligro, Princess Juneire
    Casimiro, Michael
    Guerrero, Jonathan Jaime
    Gellaco, Ma Margarita Leticia
    Lippi, Giuseppe
    Henry, Brandon Michael
    Fernandez-de-las-Penas, Cesar
    [J]. ECLINICALMEDICINE, 2022, 53
  • [4] Antiviral Treatment for COVID-19: A Systematic Review
    Arias, Francisco A.
    Teran-Chavez, Pier
    Maggi-Panato, Alessandra
    Flores-Ortega, Diego
    Rojas-Ortega, Alex
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (32) : 39 - 51
  • [5] Long-COVID: Phase 2 of the COVID-19 Pandemic
    Goetzl, Edward J.
    Kapogiannis, Dimitrios
    [J]. AMERICAN JOURNAL OF MEDICINE, 2022, 135 (11): : 1277 - 1279
  • [6] Immunology of COVID-19 and Long-COVID
    Untersmayr-Elsenhuber, Eva
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 9 - 9
  • [7] The value of COVID-19 vaccination in the context of Long-COVID
    Bauernfeind, Stilla
    Schmidt, Barbara
    [J]. INNERE MEDIZIN, 2022, 63 (08): : 840 - 850
  • [8] Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
    Khodashahi, Rozita
    Naderi, Hamidreza
    Bojdy, Amin
    Khodashahi, Mandana
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2020, 16 (03) : 165 - 183
  • [9] Safety and Efficacy of Antiviral Drugs for the Treatment of COVID-19: A Systematic Review
    Nie, Zhenwang
    Sun, Tao
    Zhao, Fangcheng
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 4457 - 4466
  • [10] Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID
    Baig, Abdul Mannan
    Greig, Nigel H.
    Gerlach, Joachim
    Salunke, Prakash
    Fabrowski, Mark
    Viduto, Valentina
    Ali, Tazeen
    [J]. ACS CHEMICAL NEUROSCIENCE, 2022, 13 (20): : 2934 - 2938
12345